Save your place

Sign in to WhoBought

Please try again later.

GeneDx Holdings Corp. (WGS) institutional ownership

Latest close $61.65 Jul 21, 2026
Market cap$3.7B 52-week range SectorHealthcare
Funds holding · Q1 2026
287
reported WGS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
136 buyers · 151 sellers

GeneDx Holdings Corp. (WGS) price and institutional activity

Dates

Q1 2026

$0 bought by 136 investors
Ark Investment Management LLCProsight Management, LP +134 more
$0 sold by 151 investors
FMR LLCT. Rowe Price Investment Management, Inc. +149 more
Bought Sold Totals per quarter; hover a bar for the names.

GeneDx Holdings Corp. (WGS) institutional activity · 287

Investor Type Est. change Change Δ Own Date
Ark Investment Management LLC Added· Q1 2026 +720K +119.1% Q1 2026
FMR LLC · Reduced
Change −537K Δ Own −64.5% Date Q1 2026
FMR LLC Reduced· Q1 2026 −537K −64.5% Q1 2026
T. Rowe Price Investment Management, Inc. · Reduced
Change −498K Date Q1 2026
T. Rowe Price Investment Management, Inc. Reduced· Q1 2026 −498K Q1 2026
Lord, Abbett & Co. LLC · Reduced
Change −476K Date Q1 2026
Lord, Abbett & Co. LLC Reduced· Q1 2026 −476K Q1 2026
Prosight Management, LP · Added
Change +468K Date Q1 2026
Prosight Management, LP Added· Q1 2026 +468K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +465K +255.0% Q1 2026
Eventide Asset Management, LLC · New
Change +459K Date Q1 2026
Eventide Asset Management, LLC New· Q1 2026 +459K Q1 2026
Summit Partners Public Asset Management, LLC · Reduced
Change −441K Date Q1 2026
Summit Partners Public Asset Management, LLC Reduced· Q1 2026 −441K Q1 2026
Driehaus Capital Management LLC · Exited
Change −395K Δ Own −100.0% Date Q1 2026
Driehaus Capital Management LLC Exited· Q1 2026 −395K −100.0% Q1 2026
T. Rowe Price Associates · Reduced
Change −391K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −391K Q1 2026
Westfield Capital Management Co LP · Added
Change +351K Date Q1 2026
Westfield Capital Management Co LP Added· Q1 2026 +351K Q1 2026
Jennison Associates LLC · Exited
Change −302K Δ Own −100.0% Date Q1 2026
Jennison Associates LLC Exited· Q1 2026 −302K −100.0% Q1 2026
Amova Asset Management Americas, Inc. · Added
Change +257K Date Q1 2026
Amova Asset Management Americas, Inc. Added· Q1 2026 +257K Q1 2026
Sumitomo Mitsui Trust Group, Inc. · Added
Change +252K Date Q1 2026
Sumitomo Mitsui Trust Group, Inc. Added· Q1 2026 +252K Q1 2026
Vestal Point Capital, LP · New
Change +250K Date Q1 2026
Vestal Point Capital, LP New· Q1 2026 +250K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 287

Famous investor activity in GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. (WGS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Gardner Mark A. · Officer Grant (A) 35K
Owned 35K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Gardner Mark A. Officer Grant (A) 35K 35K Jun 29, 2026 Jul 1, 2026
Ryan Jason · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Ryan Jason Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Ruch Joshua · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Ruch Joshua Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Ruch Joshua · Director Grant (A) 4K
Owned 4K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Ruch Joshua Director Grant (A) 4K 4K Jun 18, 2026 Jun 23, 2026
Pfenniger Richard C. Jr · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Pfenniger Richard C. Jr Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Pfenniger Richard C. Jr · Director Grant (A) 4K
Owned 4K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Pfenniger Richard C. Jr Director Grant (A) 4K 4K Jun 18, 2026 Jun 23, 2026
Meister Keith A. · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Meister Keith A. Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Meister Keith A. · Director Grant (A) 4K
Owned 4K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Meister Keith A. Director Grant (A) 4K 4K Jun 18, 2026 Jun 23, 2026
Leproust Emily M. · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Leproust Emily M. Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Leproust Emily M. · Director Grant (A) 4K
Owned 4K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Leproust Emily M. Director Grant (A) 4K 4K Jun 18, 2026 Jun 23, 2026
Fuchs Thomas · Director Grant (A) 4K
Owned 4K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Fuchs Thomas Director Grant (A) 4K 4K Jun 18, 2026 Jun 23, 2026
Casdin Eli · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Casdin Eli Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Casdin Eli · Director Grant (A) 4K
Owned 4K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Casdin Eli Director Grant (A) 4K 4K Jun 18, 2026 Jun 23, 2026
Feeley Kevin · CFO 3 operations −$227K
Price $59.75–$61.50 Qty −4K Owned 40K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Feeley Kevin CFO 3 operations $59.75–$61.50 −4K −$227K 40K Jun 16, 2026 Jun 18, 2026
Feeley Kevin · CFO 2 operations 0
Owned 22K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Feeley Kevin CFO 2 operations 0 22K Jun 16, 2026 Jun 18, 2026
15 of 84
15 of 84 Sign in to continue to older insider transactions.

GeneDx Holdings Corp. (WGS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Icahn School of Medicine At Mount Sinai 2.7M
% of shares outstanding 9.9% Filing date Nov 19, 2024
Icahn School of Medicine At Mount Sinai 2.7M 9.9% Nov 19, 2024
Goldman Sachs Group Inc 1.3M
% of shares outstanding 5.0% Filing date Nov 8, 2024
Goldman Sachs Group Inc 1.3M 5.0% Nov 8, 2024
Opko Health, Inc. 1.4M
% of shares outstanding 5.0% Filing date Nov 20, 2024
Opko Health, Inc. 1.4M 5.0% Nov 20, 2024
Blackstone Holdings III L.P. 26.8M
% of shares outstanding 3.4% Filing date Feb 3, 2023
Blackstone Holdings III L.P. 26.8M 3.4% Feb 3, 2023
Flynn James E 611K
% of shares outstanding 2.4% Filing date Jun 9, 2023
Flynn James E 611K 2.4% Jun 9, 2023
Cmls Holdings LLC 537K
% of shares outstanding 2.1% Filing date May 31, 2024
Cmls Holdings LLC 537K 2.1% May 31, 2024
Integrated Core Strategies (us) LLC 75K
% of shares outstanding 0.0% Filing date Feb 11, 2022
Integrated Core Strategies (us) LLC 75K 0.0% Feb 11, 2022
7 of 7

GeneDx Holdings Corp. (WGS) ownership FAQ

Who owns WGS?

287 reporting institutions disclosed WGS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.